Value to smokers of improved cessation products: Evidence from a willingness-to-pay survey
Autor: | Tracy Falba, Jody L. Sindelar, Susan H. Busch, Mireia Jofre-Bonet, Noelia Duchovny, Stephanie S. O'Malley |
---|---|
Rok vydání: | 2004 |
Předmět: |
Adult
Male Financing Personal Cost-Benefit Analysis medicine.medical_treatment Population Willingness to pay Environmental health medicine Humans Effective treatment education Motivation education.field_of_study Cost–benefit analysis business.industry Smoking Public Health Environmental and Occupational Health Health Care Costs Middle Aged Health Surveys Clinical trial Value (economics) Smoking cessation Female Smoking Cessation medicine.symptom business Weight gain |
Zdroj: | Nicotine & Tobacco Research. 6:631-634 |
ISSN: | 1469-994X 1462-2203 |
DOI: | 10.1080/14622200410001727885 |
Popis: | The present study demonstrated the use of willingness to pay to value hypothetical new smoking cessation products. Data came from a baseline survey of participants in a clinical trial of medications for smoking cessation (N=356) conducted in New Haven, Connecticut. We analyzed individual willingness to pay for a hypothetical tobacco cessation treatment that is (a) more effective than those currently available and then (b) more effective and attenuates the weight gain often associated with smoking cessation. A majority of the respondents (n=280; 84%) were willing to pay for the more effective treatment, and, of those, 175 (63%) were willing to pay more if the increased effectiveness was accompanied by attenuation of the weight gain associated with smoking cessation. The present study suggests the validity of using willingness-to-pay surveys in assessing the value of new smoking cessation products and products with multifaceted improvements. From these data, we calculated estimates of the value of a quit. For the population studied, this survey suggests a substantial market for more effective smoking cessation treatments. |
Databáze: | OpenAIRE |
Externí odkaz: |